Compare
Endovia Health Sciences, Inc. vs MDWerks, Inc. vs Innovation Beverage Group Ltd vs Cirtran Corp
| Latest fiscal year | Endovia Health Sciences, Inc. EDVA | MDWerks, Inc. MDWK | Innovation Beverage Group Ltd IBG | Cirtran Corp CIRX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $73.1K | $2.21M | $2.77M | $3.13M |
| Revenue growth (YoY) | -90.9% | -6.3% | -5.1% | +141.1% |
| Gross margin | 23.1% | -15.8% | 44.2% | 49.3% |
| Operating margin | n/m | -168.7% | -194.2% | -4.1% |
| Net margin | n/m | -171.5% | -223.4% | -22.4% |
| Net income | -$25.23M | -$3.80M | -$6.19M | -$701.6K |
| EPS (Diluted) | -$11.97 | -$0.02 | -$13.09 | -$0.14 |
| Operating cash flow | -$4.82M | -$1.57M | -$1.56M | -$1.34M |
| Free cash flow | n/a | -$2.45M | -$1.57M | n/a |
| Cash & equivalents | $281.4K | n/a | $127.8K | n/a |
| Total assets | $965.7K | $4.05M | $1.29M | $2.51M |
| Total liabilities | $16.27M | $3.05M | $2.76M | $27.62M |
| Shareholders' equity | -$15.30M | $1.00M | -$1.47M | -$25.11M |
| Return on year-end equity | n/a | -378.9% | n/a | n/a |
| Shares outstanding | 1.67M | 234.11M | 347.0K | 4.95M |
Revenue, most recent five fiscal years
| Fiscal year | Endovia Health Sciences, Inc. | MDWerks, Inc. | Innovation Beverage Group Ltd | Cirtran Corp |
|---|---|---|---|---|
| Latest | $73.1K Ended 2025-12-31 | $2.21M Ended 2025-12-31 | $2.77M Ended 2025-12-31 | $3.13M Ended 2025-12-31 |
| 1 year earlier | $801.3K Ended 2024-12-31 | $2.36M Ended 2024-12-31 | $2.92M Ended 2024-12-31 | $1.30M Ended 2024-12-31 |
| 2 years earlier | $18.85M Ended 2023-12-31 | $104.1K Ended 2023-12-31 | $3.15M Ended 2023-12-31 | $1.62M Ended 2023-12-31 |
| 3 years earlier | $18.09M Ended 2022-12-31 | n/a | n/a | $1.72M Ended 2022-12-31 |
| 4 years earlier | $11.32M Ended 2021-12-31 | n/a | n/a | $2.92M Ended 2021-12-31 |